Working… Menu

FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma (FORWARD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03906448
Recruitment Status : Terminated (The study was terminated because the Study Chair/IDE Sponsor and Novocure determined that conducting this trial was not feasible without CMS approval.)
First Posted : April 8, 2019
Last Update Posted : June 17, 2020
NovoCure Ltd.
Information provided by (Responsible Party):
University of Florida

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 8, 2020
Actual Study Completion Date : June 8, 2020